1 Study Coverage 1.1 Opioid Drugs Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Introduction 1.2 Global Opioid Drugs Outlook 2017 VS 2022 VS 2028 1.2.1 Global Opioid Drugs Market Size for the Year 2017-2028 1.2.2 Global Opioid Drugs Market Size for the Year 2017-2028 1.3 Opioid Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Opioid Drugs in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Opioid Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Opioid Drugs Market Dynamics 1.4.1 Opioid Drugs Industry Trends 1.4.2 Opioid Drugs Market Drivers 1.4.3 Opioid Drugs Market Challenges 1.4.4 Opioid Drugs Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Opioid Drugs by Type 2.1 Opioid Drugs Market Segment by Type 2.1.1 Buprenorphine 2.1.2 Fentanyl 2.1.3 Hydrocodone 2.1.4 Morphine 2.1.5 Oxycodone 2.1.6 Tramadol 2.1.7 Others 2.2 Global Opioid Drugs Market Size by Type (2017, 2022 & 2028) 2.3 Global Opioid Drugs Market Size by Type (2017-2028) 2.4 United States Opioid Drugs Market Size by Type (2017, 2022 & 2028) 2.5 United States Opioid Drugs Market Size by Type (2017-2028) 3 Opioid Drugs by Application 3.1 Opioid Drugs Market Segment by Application 3.1.1 Anesthesia 3.1.2 Pain relief 3.1.3 Cough suppression 3.1.4 Diarrhea suppression 3.1.5 Deaddiction 3.1.6 Others 3.2 Global Opioid Drugs Market Size by Application (2017, 2022 & 2028) 3.3 Global Opioid Drugs Market Size by Application (2017-2028) 3.4 United States Opioid Drugs Market Size by Application (2017, 2022 & 2028) 3.5 United States Opioid Drugs Market Size by Application (2017-2028) 4 Global Opioid Drugs Competitor Landscape by Company 4.1 Global Opioid Drugs Market Size by Company 4.1.1 Top Global Opioid Drugs Companies Ranked by Revenue (2021) 4.1.2 Global Opioid Drugs Revenue by Player (2017-2022) 4.2 Global Opioid Drugs Concentration Ratio (CR) 4.2.1 Opioid Drugs Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Opioid Drugs in 2021 4.2.3 Global Opioid Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Opioid Drugs Headquarters, Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Type 4.3.1 Global Opioid Drugs Headquarters and Area Served 4.3.2 Global Opioid Drugs Companies Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Opioid Drugs Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Opioid Drugs Market Size by Company 4.5.1 Top Opioid Drugs Players in United States, Ranked by Revenue (2021) 4.5.2 United States Opioid Drugs Revenue by Players (2020, 2021 & 2022) 5 Global Opioid Drugs Market Size by Region 5.1 Global Opioid Drugs Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Opioid Drugs Market Size by Region (2017-2028) 5.2.1 Global Opioid Drugs Market Size by Region: 2017-2022 5.2.2 Global Opioid Drugs Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Opioid Drugs Market Size YoY Growth 2017-2028 6.1.2 North America Opioid Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Opioid Drugs Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Opioid Drugs Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Opioid Drugs Market Size YoY Growth 2017-2028 6.3.2 Europe Opioid Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Opioid Drugs Market Size YoY Growth 2017-2028 6.4.2 Latin America Opioid Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Opioid Drugs Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Opioid Drugs Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Acura Pharmaceuticals 7.1.1 Acura Pharmaceuticals Company Details 7.1.2 Acura Pharmaceuticals Business Overview 7.1.3 Acura Pharmaceuticals Opioid Drugs Introduction 7.1.4 Acura Pharmaceuticals Revenue in Opioid Drugs Business (2017-2022) 7.1.5 Acura Pharmaceuticals Recent Development 7.2 Cipher Pharmaceutical Inc. 7.2.1 Cipher Pharmaceutical Inc. Company Details 7.2.2 Cipher Pharmaceutical Inc. Business Overview 7.2.3 Cipher Pharmaceutical Inc. Opioid Drugs Introduction 7.2.4 Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2017-2022) 7.2.5 Cipher Pharmaceutical Inc. Recent Development 7.3 Daiichi Sankyo 7.3.1 Daiichi Sankyo Company Details 7.3.2 Daiichi Sankyo Business Overview 7.3.3 Daiichi Sankyo Opioid Drugs Introduction 7.3.4 Daiichi Sankyo Revenue in Opioid Drugs Business (2017-2022) 7.3.5 Daiichi Sankyo Recent Development 7.4 Johnson＆Johnson 7.4.1 Johnson＆Johnson Company Details 7.4.2 Johnson＆Johnson Business Overview 7.4.3 Johnson＆Johnson Opioid Drugs Introduction 7.4.4 Johnson＆Johnson Revenue in Opioid Drugs Business (2017-2022) 7.4.5 Johnson＆Johnson Recent Development 7.5 Lupin Limited 7.5.1 Lupin Limited Company Details 7.5.2 Lupin Limited Business Overview 7.5.3 Lupin Limited Opioid Drugs Introduction 7.5.4 Lupin Limited Revenue in Opioid Drugs Business (2017-2022) 7.5.5 Lupin Limited Recent Development 7.6 Pfizer 7.6.1 Pfizer Company Details 7.6.2 Pfizer Business Overview 7.6.3 Pfizer Opioid Drugs Introduction 7.6.4 Pfizer Revenue in Opioid Drugs Business (2017-2022) 7.6.5 Pfizer Recent Development 7.7 Sun Pharmaceuticals 7.7.1 Sun Pharmaceuticals Company Details 7.7.2 Sun Pharmaceuticals Business Overview 7.7.3 Sun Pharmaceuticals Opioid Drugs Introduction 7.7.4 Sun Pharmaceuticals Revenue in Opioid Drugs Business (2017-2022) 7.7.5 Sun Pharmaceuticals Recent Development 7.8 Teva Pharmaceutical Industries Ltd. 7.8.1 Teva Pharmaceutical Industries Ltd. Company Details 7.8.2 Teva Pharmaceutical Industries Ltd. Business Overview 7.8.3 Teva Pharmaceutical Industries Ltd. Opioid Drugs Introduction 7.8.4 Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2017-2022) 7.8.5 Teva Pharmaceutical Industries Ltd. Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Opioid Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Opioid Drugs Market Trends Table 3. Opioid Drugs Market Drivers Table 4. Opioid Drugs Market Challenges Table 5. Opioid Drugs Market Restraints Table 6. Global Opioid Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Opioid Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Opioid Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Opioid Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Opioid Drugs Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Opioid Drugs Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Opioid Drugs Revenue Share by Player, 2017-2022 Table 13. Global Opioid Drugs Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Opioid Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Drugs as of 2021) Table 15. Top Players of Opioid Drugs in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Opioid Drugs Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Opioid Drugs Players in United States Market, Ranking by Revenue (2021) Table 20. United States Opioid Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Opioid Drugs Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Opioid Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Opioid Drugs Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Opioid Drugs Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Opioid Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Opioid Drugs Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Opioid Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Opioid Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Opioid Drugs Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Acura Pharmaceuticals Company Details Table 31. Acura Pharmaceuticals Business Overview Table 32. Acura Pharmaceuticals Opioid Drugs Product Table 33. Acura Pharmaceuticals Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 34. Acura Pharmaceuticals Recent Development Table 35. Cipher Pharmaceutical Inc. Company Details Table 36. Cipher Pharmaceutical Inc. Business Overview Table 37. Cipher Pharmaceutical Inc. Opioid Drugs Product Table 38. Cipher Pharmaceutical Inc. Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 39. Cipher Pharmaceutical Inc. Recent Development Table 40. Daiichi Sankyo Company Details Table 41. Daiichi Sankyo Business Overview Table 42. Daiichi Sankyo Opioid Drugs Product Table 43. Daiichi Sankyo Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 44. Daiichi Sankyo Recent Development Table 45. Johnson＆Johnson Company Details Table 46. Johnson＆Johnson Business Overview Table 47. Johnson＆Johnson Opioid Drugs Product Table 48. Johnson＆Johnson Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 49. Johnson＆Johnson Recent Development Table 50. Lupin Limited Company Details Table 51. Lupin Limited Business Overview Table 52. Lupin Limited Opioid Drugs Product Table 53. Lupin Limited Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 54. Lupin Limited Recent Development Table 55. Pfizer Company Details Table 56. Pfizer Business Overview Table 57. Pfizer Opioid Drugs Product Table 58. Pfizer Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 59. Pfizer Recent Development Table 60. Sun Pharmaceuticals Company Details Table 61. Sun Pharmaceuticals Business Overview Table 62. Sun Pharmaceuticals Opioid Drugs Product Table 63. Sun Pharmaceuticals Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 64. Sun Pharmaceuticals Recent Development Table 65. Teva Pharmaceutical Industries Ltd. Company Details Table 66. Teva Pharmaceutical Industries Ltd. Business Overview Table 67. Teva Pharmaceutical Industries Ltd. Opioid Drugs Product Table 68. Teva Pharmaceutical Industries Ltd. Revenue in Opioid Drugs Business (2017-2022) & (US$ Million) Table 69. Teva Pharmaceutical Industries Ltd. Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. Opioid Drugs Product Picture Figure 2. Global Opioid Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Opioid Drugs Market Size 2017-2028 (US$ Million) Figure 4. United States Opioid Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Opioid Drugs Market Size 2017-2028 (US$ Million) Figure 6. United States Opioid Drugs Market Share in Global 2017-2028 Figure 7. Opioid Drugs Report Years Considered Figure 8. Product Picture of Buprenorphine Figure 9. Product Picture of Fentanyl Figure 10. Product Picture of Hydrocodone Figure 11. Product Picture of Morphine Figure 12. Product Picture of Oxycodone Figure 13. Product Picture of Tramadol Figure 14. Product Picture of Others Figure 15. Global Opioid Drugs Market Share by Type in 2022 & 2028 Figure 16. Global Opioid Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 17. Global Opioid Drugs Market Share by Type (2017-2028) Figure 18. United States Opioid Drugs Market Share by Type in 2022 & 2028 Figure 19. United States Opioid Drugs Market Size by Type (2017-2028) & (US$ Million) Figure 20. United States Opioid Drugs Market Share by Type (2017-2028) Figure 21. Product Picture of Anesthesia Figure 22. Product Picture of Pain relief Figure 23. Product Picture of Cough suppression Figure 24. Product Picture of Diarrhea suppression Figure 25. Product Picture of Deaddiction Figure 26. Product Picture of Others Figure 27. Global Opioid Drugs Market Share by Application in 2022 & 2028 Figure 28. Global Opioid Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 29. Global Opioid Drugs Market Share by Application (2017-2028) Figure 30. United States Opioid Drugs Market Share by Application in 2022 & 2028 Figure 31. United States Opioid Drugs Market Size by Application (2017-2028) & (US$ Million) Figure 32. United States Opioid Drugs Market Share by Application (2017-2028) Figure 33. North America Opioid Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 34. U.S. Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Canada Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Europe Opioid Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 37. Germany Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. France Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. U.K. Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Italy Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Russia Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Asia-Pacific Opioid Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 43. China Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Japan Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. South Korea Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. India Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Australia Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Taiwan Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Indonesia Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Thailand Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Malaysia Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Philippines Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Latin America Opioid Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 54. Mexico Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. Brazil Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Argentina Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 57. Middle East & Africa Opioid Drugs Market Size Growth Rate 2017-2028 (US$ Million) Figure 58. Turkey Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 59. Saudi Arabia Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 60. U.A.E Opioid Drugs Market Size Growth Rate (2017-2028) & (US$ Million) Figure 61. Acura Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 62. Cipher Pharmaceutical Inc. Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 63. Daiichi Sankyo Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 64. Johnson＆Johnson Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 65. Lupin Limited Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 66. Pfizer Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 67. Sun Pharmaceuticals Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 68. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Opioid Drugs Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Acura Pharmaceuticals Cipher Pharmaceutical Inc. Daiichi Sankyo Johnson＆Johnson Lupin Limited Pfizer Sun Pharmaceuticals Teva Pharmaceutical Industries Ltd.